Probiotics in experimental and human inflammatory bowel disease: Discussion points

Digestive and Liver Disease

Volumn 38, Issue SUPPL. 2, 2006, Pages

  Pagnini, C ^a   Cominelli, F ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Animal model; Inflammatory bowel disease; Probiotic bacteria

Indexed keywords

PROBIOTIC AGENT; UNCLASSIFIED DRUG; VSL 3;

ARTICLE; BACTERIAL FLORA; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; ENTERITIS; HUMAN; LACTOBACILLUS PLANTARUM; LACTOBACILLUS SALIVARIUS; NONHUMAN;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATORY BOWEL DISEASES; PROBIOTICS;

EID: 33846420200     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(07)60008-5     Document Type: Article

References (14)

1. Guarner F., and Malagelada J. Gut flora in health and disease. Lancet 361 9356 (2003 Feb 8) 512-519
2. Gionchetti P., Amadini C., Rizzello P., Venturi A., Palmonari V., Morselli C., et al. Probiotics - role in inflammatory bowel disease. Dig Liver Dis 34 Suppl 2 (2002) S58-S62
3. Fabia R., Ar'Rajab A., Johansson M., Willen R., Andersson R., Molin G., et al. The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitisin the rat. Scand J Gastroenterol 28 2 (1993) 155-162
4. Shibolet O., Karmeli F., Eliakim R., Swennen E., Brigidi P., Gionchetti P., et al. Variable response to probiotics in two models of experimental colitis in rats. Inflamm Bowel Dis 8 6 (2002) 399-406
5. O'Mahony L., Feeney M., O'Halloran S., Murphy L., Kiely B., Fitzgibbon J., et al. Probiotic impact on microbial flora, inflammation and tumor development in IL-10 knockout mice. Aliment Pharmacol Ther 15 8 (2001) 1219-1225
6. Schultz M., Veltkamp C., Dieleman L., Grenther W., Wyrick P., Tonkonogy S., et al. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis ininterleukin-10-deficientmice. Inflamm Bowel Dis 8 2 (2002) 71-80
7. McCarthy J., O'Mahony L., O'Callaghan L., Sheil B., Vaughan E., Fitzsimons N., et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52 7 (2003) 975-980
8. Madsen K., Cornish A., Soper P., McKaigney C., Jijon H., Yachimec C., et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121 3 (2001) 580-591
9. Rachmilewitz D., Katakura K., Karmeli F., Hayashi T., Reinus C., Rudensky B., et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126 2 (2004) 520-528
10. Di Giacinto C., Marinaro M., Sanchez M., Strober W., and Boirivant M. Probiotics ameliorate recurrent Thl-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 174 6 (2005) 3237-3246
11. Matsumoto S., Hara T., Hori T., Mitsuyama K., Nagaoka M., Tomiyasu N., et al. Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol 140 3 (2005) 417-426
12. Babiloni R., Fedorak R., Tannock G., Madsen K., Gionchetti P., Campieri M., et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100 7 (2005) 1539-1546
13. Jijon H., Backer J., Diaz H., Yeung H., Thiel D., McKaigney C., et al. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 126 5 (2004) 1358-1373
14. Sheil B., McCarthy J., O'Mahony L., Bennett M., Ryan P., Fitzgibbon J., et al. Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 53 5 (2004) 694-700